Global Protein Sequencing Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Sample Preparation, MS, Sequencer, Reagent, and Consumable.By End user;
Academia, Pharma, Biotechnology, and CROs.By Technology;
Mass Spectrometry and Edman Degradation.By Application;
Biotherapeutics, Genetic Engineering and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Protein Sequencing Market (USD Million), 2021 - 2031
In the year 2024, the Global Protein Sequencing Market was valued at USD 1,740.35 million. The size of this market is expected to increase to USD 2,247.37 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.7%.
The global protein sequencing market is experiencing significant growth driven by advancements in proteomics research, expanding applications in drug discovery and development, and rising demand for personalized medicine. Protein sequencing, the process of determining the precise order of amino acids in a protein, is fundamental to understanding protein structure, function, and interactions. With the increasing complexity of biological systems and the critical role of proteins in disease mechanisms, there is a growing need for accurate and high-throughput protein sequencing technologies, driving market expansion.
Technological advancements in protein sequencing platforms, such as mass spectrometry-based methods and next-generation sequencing technologies, are driving market growth by enabling rapid, sensitive, and comprehensive analysis of protein sequences. These advancements offer researchers unprecedented insights into the proteome, facilitating the identification of disease biomarkers, drug targets, and personalized treatment strategies. Additionally, the integration of bioinformatics tools and machine learning algorithms enhances data analysis and interpretation, further driving the adoption of protein sequencing technologies in biomedical research and clinical diagnostics.
Furthermore, the increasing adoption of protein sequencing in drug discovery and development presents lucrative opportunities for market players. Protein sequencing enables the characterization of therapeutic proteins, such as monoclonal antibodies and recombinant proteins, ensuring their quality, safety, and efficacy. Moreover, protein sequencing plays a crucial role in understanding drug-protein interactions, pharmacokinetics, and immunogenicity, thereby guiding drug optimization and development processes. With the growing emphasis on precision medicine and targeted therapies, the global protein sequencing market is poised for continued growth, fueled by advancements in technology and expanding applications across various sectors of the life sciences industry.
Global Protein Sequencing Market Recent Developments
-
In July 2024, The protein sequencing market expanded from $1.55 billion in 2023 to $1.7 billion in 2024, with drivers including diagnostic applications, pharmaceuticals, and advancements in genetic and environmental research
-
In February 2024, Quantum-Si introduced the Protein Sequencing Kit V2, enhancing protein sequencing performance, and reducing costs, especially beneficial for applications in proteomics research and biomarker discovery
Segment Analysis
The Global Protein Sequencing Market has been segmented by product, end user, technology, and application, each influencing the market's expansion and development in different ways. The product segment, including sample preparation, mass spectrometry (MS), sequencers, reagents, and consumables, plays a significant role in driving the market forward. Advancements in each of these areas have contributed to the growing demand for protein sequencing tools. For instance, sample preparation technologies ensure accurate protein extraction and analysis, while mass spectrometry and sequencers are critical for protein identification and characterization. Reagents and consumables, necessary for various sequencing processes, continue to evolve, offering researchers improved accuracy, speed, and efficiency. The demand for these products is expected to rise as the need for more advanced proteomics research and clinical diagnostics increases.
End-user segmentation, encompassing academia, pharmaceutical companies, biotechnology firms, and contract research organizations (CROs), also plays a pivotal role in shaping the market. Academic institutions, which are major users of protein sequencing technologies, drive demand for these tools for basic and applied research, especially in proteomics, biomarker discovery, and disease research. Pharmaceutical companies and biotechnology firms use protein sequencing in drug discovery, target validation, and the development of biologic drugs, creating a strong market demand. Additionally, contract research organizations provide protein sequencing services for pharmaceutical and biotechnology companies, further fueling the growth of the market as drug development and clinical trials become more dependent on external research services.
The technology segment in the protein sequencing market also contributes significantly to its growth, with techniques such as mass spectrometry, next-generation sequencing (NGS), and Edman degradation continuing to evolve. Mass spectrometry, particularly, plays a central role in protein sequencing due to its ability to identify and quantify proteins with high accuracy and sensitivity. NGS technology, which has seen considerable advancements, allows for high-throughput protein sequencing, providing insights into protein structure and function across a wide array of samples. These technological innovations make protein sequencing more accessible, faster, and more affordable, driving its increased adoption in various research and clinical applications.
Applications in antibody characterization, clinical diagnostics, proteomics, and others further boost the demand for protein sequencing technologies. In antibody characterization, protein sequencing aids in developing more effective therapeutic antibodies, ensuring their specificity and efficacy. Clinical diagnostics rely on protein sequencing for biomarker identification, early disease detection, and personalized treatment strategies. The proteomics application, which involves large-scale studies of proteins and their functions, continues to grow as researchers explore protein expression profiles and the role of proteins in various diseases. As new applications emerge, such as in food safety and environmental monitoring, protein sequencing’s role in diverse sectors continues to expand, further driving the overall market's growth.
Global Protein Sequencing Segment Analysis
In this report, the Global Protein Sequencing Market has been segmented by Product, End user, Technology, Application and Geography.
Global Protein Sequencing Market, Segmentation by Product
The Global Protein Sequencing Market has been segmented by Product into Sample Preparation, MS, Sequencer, Reagent, and Consumable.
These segments reflect the diverse needs of researchers and clinical laboratories as they strive for more accurate and efficient protein analysis, contributing to the continued growth and innovation in the field.
Sample preparation is a critical step in the protein sequencing process, ensuring that proteins are properly extracted, purified, and prepared for analysis. It involves a range of techniques such as protein denaturation, digestion, and fractionation to prepare the protein sample in a form suitable for sequencing. Advances in sample preparation technology are improving the quality and efficiency of sequencing, helping to reduce errors and increase throughput. This segment is essential for the accurate analysis of complex biological samples, and its growth is driven by the increasing demand for high-quality protein data in both research and clinical settings.
Mass spectrometry (MS) is a key technology used in protein sequencing to identify and quantify proteins based on their mass-to-charge ratio. MS is widely used for protein identification, quantification, and characterization, enabling researchers to analyze protein structure, function, and interactions. The increasing adoption of mass spectrometry in proteomics research and clinical diagnostics is driving the growth of this segment. Advances in MS technology, such as higher resolution and sensitivity, are expanding its applications, making it an essential tool in protein sequencing for complex biological studies and disease investigations.
Sequencers are specialized instruments used to determine the amino acid sequences of proteins. These devices are central to the protein sequencing workflow and are continually evolving to provide faster, more accurate results with higher throughput. The growing demand for proteomic research, personalized medicine, and biomarker discovery is fueling the need for more advanced sequencers capable of processing larger and more complex datasets. As sequencing technologies improve, sequencers are becoming increasingly accessible and essential for both academic research and clinical applications, particularly in genomics and proteomics studies.
Reagents and consumables support the protein sequencing process by providing the necessary chemicals and materials required for sample preparation, analysis, and data interpretation. Reagents are used for protein digestion, labeling, and other biochemical reactions that enable sequencing, while consumables such as columns, filters, and labware ensure the proper functioning of sequencing instruments. As the demand for high-throughput protein analysis grows, so too does the need for high-quality reagents and consumables. This segment is expected to continue growing as researchers and clinicians require more efficient and reliable products to support their sequencing efforts.
Global Protein Sequencing Market, Segmentation by End user
The Global Protein Sequencing Market has been segmented by End user into Academia, Pharma, Biotechnology, and CROs.
These end users leverage protein sequencing for various applications, including basic research, drug development, and clinical testing, contributing to the continued expansion of the market.
Academia is one of the largest end-user segments in the protein sequencing market, driven by the increasing need for advanced tools in proteomics and molecular biology research. Academic institutions and research organizations utilize protein sequencing technologies to explore protein functions, understand cellular mechanisms, and identify biomarkers for various diseases. The growing focus on personalized medicine and the discovery of novel therapeutic targets in academic settings is further propelling the demand for protein sequencing. The integration of proteomics with genomics and systems biology is expected to drive continued growth in this segment as researchers seek to uncover more complex biological relationships.
The pharmaceutical industry represents another key end user of protein sequencing technologies, primarily for drug discovery and development. Pharmaceutical companies use protein sequencing to identify drug targets, characterize protein functions, and develop biologic drugs, such as monoclonal antibodies and other protein-based therapeutics. Protein sequencing also plays a crucial role in the validation of biomarkers, which are essential for the development of diagnostic tests and precision medicine. With the growing emphasis on biologics and personalized therapies, pharmaceutical companies are increasingly adopting protein sequencing as part of their research and development processes, ensuring the segment’s continued growth.
Biotechnology companies also form a significant portion of the protein sequencing market, utilizing these technologies for various applications, including diagnostics, biomanufacturing, and therapeutic development. Biotechnology firms rely on protein sequencing to develop new therapeutic proteins, gene editing technologies, and diagnostic platforms. As the biotechnology industry expands, particularly in the fields of gene therapy and cell-based therapies, the demand for protein sequencing to support these innovations continues to rise. The need for high-throughput and accurate protein sequencing is particularly pronounced in the biotech sector, where rapid product development and quality control are essential for market success.
Contract research organizations (CROs) are increasingly adopting protein sequencing to support pharmaceutical, biotechnology, and academic clients in their research efforts. CROs provide outsourced research services, including protein sequencing, for drug discovery, biomarker validation, and clinical trials. As the pharmaceutical and biotechnology industries continue to outsource various stages of research and development to CROs, the demand for protein sequencing services has grown. CROs play a crucial role in accelerating drug development timelines, and their reliance on advanced proteomics technologies, including protein sequencing, is expected to continue rising, further expanding this segment of the market.
Global Protein Sequencing Market, Segmentation by Technology
The Global Protein Sequencing Market has been segmented by Technology into Mass Spectrometry and Edman Degradation.
The global protein sequencing market has been segmented by technology into two primary methods: mass spectrometry and Edman degradation. Mass spectrometry-based protein sequencing has emerged as a leading technology due to its high sensitivity, accuracy, and versatility in analyzing complex protein samples. This method involves ionizing proteins, separating ions based on their mass-to-charge ratio, and then detecting and analyzing the resulting mass spectra to determine the amino acid sequence. Mass spectrometry offers significant advantages, including the ability to analyze a wide range of protein sizes and post-translational modifications, making it invaluable in proteomics research and drug discovery applications.
On the other hand, Edman degradation remains a well-established method for protein sequencing, particularly for smaller proteins and peptides. This method involves selectively removing and identifying the N-terminal amino acid residue of a protein or peptide through a series of chemical reactions. While Edman degradation has limitations in terms of throughput and sensitivity compared to mass spectrometry, it remains a valuable tool, especially for sequencing short peptides and validating sequence data obtained from other methods. Additionally, advancements in Edman degradation techniques, such as automated instrumentation and improved reagents, have enhanced its efficiency and applicability in certain research and clinical settings.
The segmentation of the protein sequencing market into mass spectrometry and Edman degradation reflects the diverse needs and preferences of researchers and clinicians in different applications and experimental contexts. While mass spectrometry dominates the market due to its advanced capabilities and widespread adoption, Edman degradation continues to play a complementary role, particularly in specific niche areas. As technology continues to evolve and new innovations emerge, the global protein sequencing market is expected to witness further growth and diversification, driven by ongoing advancements in both mass spectrometry and Edman degradation techniques.
Global Protein Sequencing Market, Segmentation by Application
The Global Protein Sequencing Market has been segmented by Application into Biotherapeutics, Genetic Engineering and Others.
The global protein sequencing market has been segmented by application into biotherapeutics, genetic engineering, and others, reflecting the diverse uses of protein sequencing technologies across various sectors. In the field of biotherapeutics, protein sequencing plays a crucial role in ensuring the quality, safety, and efficacy of therapeutic proteins such as monoclonal antibodies, recombinant proteins, and vaccines. By accurately determining the amino acid sequence of these biopharmaceuticals, protein sequencing technologies help manufacturers characterize and validate their products, ensuring compliance with regulatory standards and guiding drug optimization processes.
In genetic engineering, protein sequencing is essential for understanding the structure-function relationships of proteins and their role in biological processes. By deciphering the amino acid sequence of proteins encoded by genes, researchers can gain insights into protein function, interactions, and regulatory mechanisms. Protein sequencing technologies enable the identification of gene mutations, protein isoforms, and post-translational modifications, providing valuable information for genetic engineering applications such as protein engineering, synthetic biology, and metabolic engineering.
Beyond biotherapeutics and genetic engineering, protein sequencing finds applications in various other fields, including basic research, clinical diagnostics, and food science. In basic research, protein sequencing technologies facilitate the study of protein-protein interactions, signaling pathways, and disease mechanisms, advancing our understanding of biology and disease. In clinical diagnostics, protein sequencing plays a crucial role in biomarker discovery, disease diagnosis, and personalized medicine, enabling the identification of disease-specific protein signatures and guiding treatment decisions. In food science, protein sequencing is used for quality control, authentication, and safety assessment of food products, ensuring compliance with regulatory standards and meeting consumer demands for transparency and traceability. Overall, the segmentation of the global protein sequencing market by application reflects the diverse uses and expanding opportunities for protein sequencing technologies across multiple sectors of the life sciences industry.
Global Protein Sequencing Market, Segmentation by Geography
In this report, the Global Protein Sequencing Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Protein Sequencing Market Share (%), by Geographical Region, 2024
The global protein sequencing market share varies across different geographical regions, reflecting disparities in healthcare infrastructure, research capabilities, and market dynamics. North America holds a significant portion of the market share, driven by factors such as advanced research facilities, strong academic and industrial collaborations, and high healthcare expenditure. The region benefits from a robust ecosystem of biotechnology and pharmaceutical companies, which drive innovation and adoption of protein sequencing technologies. Additionally, favorable government initiatives and regulatory frameworks support research and development activities, further contributing to North America's dominance in the protein sequencing market.
Europe also commands a substantial market share in the global protein sequencing market, attributed to well-established healthcare systems, renowned research institutions, and a thriving biotechnology sector. Countries such as Germany, the UK, and France are key contributors to the region's market share, with significant investments in proteomics research and drug discovery efforts. Moreover, increasing partnerships between academia and industry, along with initiatives promoting translational research and personalized medicine, are driving market growth in Europe. However, market growth in the region may face challenges such as stringent regulatory requirements and economic uncertainties.
Asia-Pacific represents a region with immense growth potential in the protein sequencing market. The region's market share is expanding rapidly due to rising investments in healthcare infrastructure, growing research capabilities, and increasing adoption of advanced technologies. Countries like China, Japan, and India are at the forefront of proteomics research and are witnessing a surge in demand for protein sequencing technologies, driven by the rising prevalence of chronic diseases and the need for personalized healthcare solutions. Moreover, government initiatives promoting biotechnology innovation and the presence of a large pool of skilled professionals are further propelling market growth in the Asia-Pacific region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Protein Sequencing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Advancements in Proteomics Research
- Growing Demand for Personalized Medicine
-
Expanding Applications in Drug Discovery - The global protein sequencing market is experiencing significant growth, largely propelled by expanding applications in drug discovery. Protein sequencing plays a pivotal role in elucidating the structure and function of proteins, thereby aiding in the identification of potential drug targets and the optimization of therapeutic molecules. As the pharmaceutical industry continues to shift towards targeted therapies and precision medicine, there is an increasing demand for accurate and comprehensive protein sequencing technologies to facilitate drug discovery processes.
Protein sequencing enables the characterization of therapeutic proteins, such as monoclonal antibodies, enzymes, and receptors, ensuring their quality, safety, and efficacy. By accurately determining the amino acid sequence of therapeutic proteins, researchers can assess their structural integrity, post-translational modifications, and biological activity, critical factors influencing their pharmacological properties. Additionally, protein sequencing facilitates the identification of protein isoforms, splice variants, and protein-protein interactions, providing valuable insights into disease mechanisms and potential therapeutic interventions.
Protein sequencing plays a crucial role in understanding drug-protein interactions, pharmacokinetics, and pharmacodynamics, guiding drug optimization and development processes. By elucidating the binding sites and mechanisms of action of therapeutic molecules, protein sequencing enables the rational design of novel drug candidates with improved efficacy and reduced off-target effects. Furthermore, protein sequencing technologies, such as mass spectrometry-based methods and next-generation sequencing, offer high-throughput capabilities, enabling rapid and comprehensive analysis of protein sequences, thereby accelerating drug discovery workflows. Overall, the expanding applications of protein sequencing in drug discovery present lucrative opportunities for market players and are poised to drive further growth in the global protein sequencing market.
Restraints
- High Costs of Sequencing Technologies
- Complex Data Analysis
-
Regulatory Compliance Challenges - Regulatory compliance poses a significant challenge to the global protein sequencing market, particularly concerning the validation and standardization of sequencing technologies and methodologies. Regulatory bodies worldwide, such as the FDA in the United States and the EMA in Europe, impose stringent requirements for the validation and approval of sequencing platforms and assays used in biomedical research and clinical diagnostics. Ensuring compliance with these regulations necessitates extensive validation studies, documentation of assay performance characteristics, and adherence to quality assurance protocols, which can be time-consuming and resource-intensive for companies operating in the protein sequencing market.
The evolving regulatory landscape adds complexity to compliance efforts in the protein sequencing industry. As technologies and methodologies continue to advance rapidly, regulatory agencies may struggle to keep pace with emerging trends and innovations in protein sequencing. This dynamic regulatory environment can lead to uncertainties and inconsistencies in regulatory requirements, making it challenging for companies to navigate compliance processes effectively. Additionally, differences in regulatory standards across regions and countries further complicate compliance efforts, requiring companies to adapt their strategies and documentation to meet diverse regulatory requirements.
Despite these challenges, addressing regulatory compliance is essential for ensuring the safety, reliability, and efficacy of protein sequencing technologies and assays. Companies in the protein sequencing market must prioritize compliance by investing in robust quality management systems, conducting comprehensive validation studies, and maintaining transparent communication with regulatory agencies. Collaborative efforts between industry stakeholders, regulatory bodies, and academic institutions can facilitate the development of standardized guidelines and best practices for regulatory compliance in protein sequencing, ultimately fostering innovation and driving market growth.
Opportunities
- Technological Innovations
- Integration of Bioinformatics
-
Expansion in Drug Development - Expansion in drug development represents a significant opportunity driving growth in the global protein sequencing market. Protein sequencing plays a crucial role in drug discovery and development by enabling the characterization of therapeutic proteins, validation of drug targets, and identification of potential biomarkers. As the pharmaceutical industry continues to focus on developing targeted therapies and biologics, there is a growing demand for accurate and comprehensive protein sequencing technologies to ensure the quality, safety, and efficacy of therapeutic proteins.
Protein sequencing facilitates the optimization of biologic drugs, such as monoclonal antibodies and recombinant proteins, by providing insights into their structure, function, and post-translational modifications. By understanding the precise amino acid sequence of therapeutic proteins, researchers can identify critical regions responsible for biological activity and immunogenicity, guiding rational drug design and formulation. Moreover, protein sequencing enables the characterization of impurities and variants in biologic drugs, ensuring product quality and regulatory compliance throughout the drug development process.
Protein sequencing plays a pivotal role in elucidating drug-protein interactions and pharmacokinetics, informing drug optimization and development strategies. By identifying drug targets and understanding their binding mechanisms, researchers can design more effective and selective therapeutic agents with improved clinical outcomes. Furthermore, protein sequencing facilitates the identification of potential biomarkers for patient stratification and treatment response prediction, supporting the development of personalized medicine approaches. Overall, the expansion of protein sequencing applications in drug development underscores its importance in advancing pharmaceutical research and innovation.
Competitive Landscape Analysis
Key players in Global Protein Sequencing Market include:
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Bruker Corporation
- Waters Corporation
- Shimadzu Corporation
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- GE Healthcare (a subsidiary of General Electric Company)
- Danaher Corporation
- Sartorius AG
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End user
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By Region
- Global Protein Sequencing Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Advancements in Proteomics Research
- Growing Demand for Personalized Medicine
- Expanding Applications in Drug Discovery
- Restraints
- High Costs of Sequencing Technologies
- Complex Data Analysis
- Regulatory Compliance Challenges
- Opportunities
- Technological Innovations
- Integration of Bioinformatics
- Expansion in Drug Development
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Protein Sequencing Market, By Product, 2021 - 2031 (USD Million)
- Sample Preparation
- MS, Sequencer
- Reagent
- Consumable
- Global Protein Sequencing Market, By End user, 2021 - 2031 (USD Million)
- Academia
- Pharma
- Biotechnology
- CROs
- Global Protein Sequencing Market, By Technology, 2021 - 2031 (USD Million)
- Mass Spectrometry
- Edman Degradation
- Global Protein Sequencing Market, By Application, 2021 - 2031 (USD Million)
- Biotherapeutics
- Genetic Engineering
- Others
- Global Protein Sequencing Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Protein Sequencing Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Bruker Corporation
- Waters Corporation
- Shimadzu Corporation
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- GE Healthcare (a subsidiary of General Electric Company)
- Danaher Corporation
- Sartorius AG
- Company Profiles
- Analyst Views
- Future Outlook of the Market